Rxi Pharmaceuticals Corp (NASDAQ:RXII)

0.7287
Delayed Data
As of Apr 20
 +0.0037 / +0.51%
Today’s Change
0.68
Today|||52-Week Range
4.30
-54.46%
Year-to-Date

Today’s Trading

Previous close0.73
Today’s open0.73
Day’s range-- - --
Volume990,303
Average volume (3 months)740,935
Market cap$22.8M
Dividend yield--
Data as of 04/20/2015

Growth & Valuation

Earnings growth (last year)+72.57%
Earnings growth (this year)+56.33%
Earnings growth (next 5 years)--
Revenue growth (last year)-82.21%
P/E ratioNM
Price/Sales368.74
Price/Book13.73

Competitors

 Today’s
change
Today’s
% change
CANFCan Fite Biopharma L...0.000.00%
CBMXCombiMatrix Corp+0.05+2.70%
ICCCImmuCell Corp0.000.00%
WGBSWaferGen Bio-systems...-0.11-2.32%
Data as of 04/20/2015

Financials

Next reporting dateMay 13, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$71.0K
Annual profit (last year)-$8.8M
Net profit margin-12,394.37%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Geert Cauwenbergh
Vice President-
Research
Karen Bulock
Corporate headquarters
Westborough, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers